- B12 -

Improving Europewide awareness understanding and access to diagnosis and treatment of inherited lipid conditions About Us Our Mission Our Objectives Our Strategy Our mission is to improve Europewide awareness understanding and access to diagnosis and treatment of inherited lipid conditions specifically FH HoFH Lpa FCS so that all those impacted receive optimal treatment and support resulting in longer and healthier lives. Our vision is to achieve early recognition of lifethreatening dyslipidaemias for all impacted people in a future where So that together with our Network patient organizations and other stakeholders we will be able to prevent the consequences among them premature heart attacks and deaths of inherited dyslipidaemias. FH Europe Foundation FHEF has as its object the advancement of health the prevention of early atherosclerotic cardiovascular diseases ASCVD and other diseases as a consequence of inherited dyslipidaemias in particular through timely screening diagnosis and treatment as well as education health literacy promotion access to treatment and related health policy influencing. The FHEF foundation will specifically but not exclusively devote itself to the following activities To deliver on its mission FHEF identified the following strategic projects Governance Impact Report Financial Statement Policies Our impact reports are available to download FH Europe has been registered as a foundation Stichting FH Europe Foundation in the Netherlands KvK number 86407481 RSIN number 863956762 since May 17th 2022.